Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration
Author:
Affiliation:
1. Departments of †Medicinal Chemistry and ‡Chemistry, University of Michigan, 930 North University Avenue, Ann Arbor, Michigan 48109, United States
Funder
University of Michigan
National Institute of General Medical Sciences
College of Pharmacy, University of Michigan
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.5b00167
Reference29 articles.
1. The Protein Kinase Complement of the Human Genome
2. Protein kinases — the major drug targets of the twenty-first century?
3. Targeting cancer with small molecule kinase inhibitors
4. Kinase Drug Discovery – What’s Next in the Field?
5. Substrate Activity Screening with Kinases: Discovery of Small-Molecule Substrate-Competitive c-Src Inhibitors
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities;Bioorganic Chemistry;2024-01
2. Biocompatible reactions: advances in kinetic target-guided synthesis;Trends in Chemistry;2023-09
3. Linkers in fragment-based drug design: an overview of the literature;Expert Opinion on Drug Discovery;2023-07-19
4. Designing drugs and chemical probes with the dualsteric approach;Chemical Society Reviews;2023
5. Design, synthesis, and evaluation of peptide‐imidazo[1,2‐ a ]pyrazine bioconjugates as potential bivalent inhibitors of the VirB11 ATPase HP0525;Journal of Peptide Science;2021-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3